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Abstract
An understanding of the immunological footprint of Mycobacterium tuberculosis (MTB) CD4 T cell recognition is still
incomplete. Here we report that human Th1 cells specific for MTB are largely contained in a CXCR3+CCR6+ memory subset
and highly focused on three broadly immunodominant antigenic islands, all related to bacterial secretion systems. Our
results refute the notion that secreted antigens act as a decoy, since both secreted proteins and proteins comprising the
secretion system itself are targeted by a fully functional T cell response. In addition, several novel T cell antigens were
identified which can be of potential diagnostic use, or as vaccine antigens. These results underline the power of a truly
unbiased, genome-wide, analysis of CD4 MTB recognition based on the combined use of epitope predictions, high
throughput ELISPOT, and T cell libraries using PBMCs from individuals latently infected with MTB.
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Introduction
Tuberculosis is one of the major causes of death from infectious
disease. Current diagnostics do not distinguish active and latent
infection, and the only available vaccine has limited efficacy.
Hence, there is an urgent need for both novel vaccines and
diagnostic strategies.
Human T cell responses to MTB involve CD4, CD8, CD1 and
ch T cells. Seminal studies showed that human memory T helper 1
(Th1) cells directed against the purified protein derivative (PPD) of
MTB secreted IFN-c [1]. IFN-c has an essential role in the
protective immunity to mycobacteria, as individuals with genetic
defects in the IFN-c receptor has an increased susceptibility to
mycobacteria [2]. Th1 cells mainly express the chemokine receptors
CCR5 and CXCR3 [3], while Th17 cells co-express CCR6 and
CCR4 and Th22 cells co-express CCR6 and CCR10 [4,5].
While several studies have reported the identification of MTB
antigens, from abundant or easily purified proteins [6,7], a truly
genome-wide study to identify antigens is lacking. In only a few
cases have techniques allowing ex vivo detection and/or charac-
terization of MTB-specific T cells, prior to any in vitro expansion
and manipulations, been utilized [8,9,10].
A key issue relating to MTB immunity is whether different
classes of antigens elicit responses that have the same or diverse
functional characteristics. MTB antigens described so far are
predominantly secreted MTB proteins [11], Some of which are
not essential for bacterial survival [12]. As a result, it was
hypothesized that secreted proteins might act as decoy antigens,
diverting the immune response from recognizing more relevant
MTB proteins [13].
In this regard, two intriguing MTB protein categories are the
PE/PPE proteins, and the Esx protein family, which have been
shown to elicit B and T cell responses [14,15]. The function(s) of
PE/PPE proteins are not fully understood but data indicates that
they influence antigen presentation and host cell apoptosis [15].
The PE/PPE genes encode almost 200 proteins (4% of the total
open reading frames (ORFs)) [16], unique to Mycobacteria and
most prevalent in pathogenic strains. While PE/PPE proteins are
mainly located within the bacterial cell wall and cell surface, some
are also secreted [17,18].
PE/PPE genes are closely related to the Esx regions [19]. These
regions encode Type VII secretion systems (T7SS), also known as
Esx secretion systems. Five related, but functionally distinct and
non cross-complementing T7SS (Esx 1–5), are present in MTB
[20]. The best characterized is Esx-1, which encodes the Rv3874
(culture filtrate protein 10 kDa, CFP10) and Rv3875 (early
secretory antigenic target 6 kDa, ESAT-6) antigens [20]. The
genes encoding the Esx proteins, are arranged in tandem pairs
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(EsxA-W) at 11 genomic loci [21]. Esx secreted proteins have been
detected from Esx-1, -3 and -5 indicating that these are functional
secretion systems [22].
T cell epitopes have been described from all main MTB protein
categories, indicating that protein function or cellular location per
se does not determine which proteins can be recognized. Previous
studies in complex pathogen systems demonstrated that immune
responses are directed against a relatively large fraction of the
genome [23,24]. However, epitope reactivity is currently described
only from about 4% of the approximately 4,000 ORFs of the
MTB genome ([11] (IEDB, www.iedb.org)). Hence, we hypoth-
esized that a genome-wide probe of the immunogenicity of MTB
ORFs would reveal a large number of novel antigens. Defining the
breadth of responses is key for the design of vaccination strategies
that mirror natural immunity [25], evaluation of disease the
performance of vaccine candidates and the development of
diagnostics.
By combining HLA class II peptide binding predictions with
modern high throughput techniques such as ex vivo ELISPOT
analysis, HLA class II multimers, and the screening of T cell
libraries [26], we were able for the first time to identify and
characterize the genome-wide antigen response in latently infected
individuals.
Results
Breadth and Dominance of a Genome-wide Library of
MTB-derived Predicted HLA Class II Epitopes in LTBI
Donors
Protein sequences from five complete MTB genomes
(CDC1551, F11, H37Ra, H37Rv and KZN 1435) and sixteen
draft assemblies from the NCBI Protein database (Table S1) were
aligned. The binding capacity of all possible 15-mer peptides
(n = 1,568,148) was predicted for 22 HLA DR, DP and DQ class
II alleles (Figure S1 and Table S2) most commonly expressed in
the general population [27], to select peptides predicted to bind
multiple HLA class II alleles (promiscuous epitopes). This
approach identifies the most dominant and prevalent responses,
corresponding to approximately 50% of the total overall response
[27].
A total of 20,610 peptides (with a range of 2 to 10 per ORF, and
an average of 5), including 1,660 variants not totally conserved
amongst the genomes considered in the analysis, were synthesized
and arranged into 1,036 peptide pools of 20 peptides (Figure S1).
The ex vivo production of IFN-c by PBMCs from 28 LTBI donors
induced by each of the 1,036 pools was measured utilizing
ELISPOT. Pools recognized by $10% of donors were deconvo-
luted, and 369 individual MTB epitopes were identified (Table
S3). Individual donors recognized, on average, 24 epitopes,
underlining the large breadth of response to MTB.
Epitope responses were ranked on the basis of magnitude to
assess their relative dominance. The top 80 epitopes accounted for
75% of the total response and the top 175 epitopes accounted for
90% of the total response (Figure 1A). Only occasional weak
responses were detected in 28 TB uninfected/non-Bacille Calm-
ette-Gue´rin (BCG) vaccinated control donors, thus demonstrating
that these responses were LTBI-specific (Figure 1A). The epitopes
were mapped to individual MTB antigens using the H37Rv as a
reference genome. A total of 82 antigens were recognized by more
than 10% of LTBI donors (Figure 1B). These 82 antigens
accounted for approximately 80% of the total response in LTBI
donors (Figure 1C). Responses to the epitopes from the most
frequently recognized antigens were further characterized utilizing
PBMCs depleted of either CD4 or CD8 T cells. The majority
(97%) of these epitopes were recognized exclusively by CD4 T
cells (Table S3), as expected because of their identification on the
basis of predicted HLA class II binding capacity.
Novel MTB Antigens and Sources of CD4 T Cell Epitopes
Recognized by LTBI Donors
Comparing these 82 most prevalently recognized antigens with
antigens for which similar ex vivo epitope reactivity has been
described (IEDB), we found that the majority (61/82 antigens,
74%) was novel. While a given antigen might not have been
analyzed in sufficient detail to lead to the description of defined
epitopes, it might nevertheless have been described as a target of T
cell responses. Therefore we performed a literature search for each
individual antigen to further categorized them as novel, or as
targets of CD4 T cells, CD8 T cells or undefined T cell type. This
revealed that 41% of the antigens we identified had not previously
been described as T cell targets (Figure S2A and Table 1). The
responses to novel antigens, in terms of both response frequency
and magnitude, are comparable to those directed against
previously known T cell targets (Table S4).
Further analysis of the IEDB data revealed a limited overlap,
(18%; 28/158) between antigens identified in this study and
antigens known as sources of HLA class I epitopes (Figure S2B).
Finally, no significant correlation was found with the antigens
recognized by serological responses from the MTB proteome [28]
(Figure S2C).
HLA Class II Reactivity Is Highly Focalized on MTB
Antigenic Islands
Next, using the TubercuList database [16], we determined the
protein category to which the identified antigens belong (Figure 2).
As expected, the identified antigens were associated with almost
every category, with the exception of regulatory proteins and
proteins of unknown function. The significant overrepresentation
of PE/PPE proteins was notable, as well as the underrepresenta-
tion of proteins in the conserved hypotheticals, cellular metabolism
and respiration categories.
Author Summary
Mycobacterium tuberculosis is one of the most life-
threatening pathogens of all time, having infected one-
third of the present human population. There is an urgent
need for both novel vaccines and diagnostic strategies.
Here, we were able to identify the targets most dominantly
recognized by latently infected individual that successfully
contain infection. These targets are contained in three
broadly genomic antigenic islands, all related to bacterial
secretion systems and composed by several distinct ORFs.
Thus, our results suggest that vaccination with one or few
defined antigens will fail to replicate the response
associated with natural immunity. Our analysis also
pinpoints that the Th1 cells dominating the response are
associated with novel and well-defined phenotypic mark-
ers, suggesting that the response is molded by unique
MTB associated factors. This study demonstrates further
that the approach combining peptide binding predictions
with modern high throughput techniques is generally
applicable to the study of immunity to other complex
pathogens. Together, our data provide a new angle in the
worldwide fight against M. tuberculosis and could be used
for diagnostic or vaccine developments.
Definition of Immunosignatures Associated with MTB
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The localization of antigens recognized was next visualized by
plotting the recognition data on a linear map of the MTB genome.
Analysis of either percent of donors responding or percent of total
response revealed striking clusters of reactivity within certain
regions of the genome (Figure 3A). When the MTB genome was
parsed into 5-gene windows, significant antigenic clusters (defined
by minimum 4 proteins within the 5-gene window being
recognized by 7.1% of LTBI donors) could be identified using
binomial distribution probability and Bonferroni correction. Three
significant antigenic islands (Figure 3B), encoding 0.55% of the
total ORFs, accounted for 42% of the total response (Table 2).
One of the islands (Island 3) contains the well-known Rv3875 and
Rv3874 antigens, which is an Esx protein pair secreted via a
T7SS. Strikingly, the other two islands also contain Esx protein
pairs. Moreover, two of the antigenic islands are part of the known
T7SS systems Esx-1 (Island 3) and Esx-3 (Island 1). It is
noteworthy that the proteins recognized included not only the
proteins believed to be secreted, but also the proteins forming the
actual secretion apparatus (Island 1). Indeed, the antigens
identified within these islands correspond to proteins from several
different protein categories, mostly assigned to the cell wall and
cellular processes and the PE/PPE category, which is not
surprising since several of these proteins are part of the T7SS.
Additionally, Rv3615c [29], which is functionally linked to Esx-1
[30], was also prevalently recognized. However, it stands as a
single antigen and not as part of an antigenic island.
Antigenic Islands Rather than PE/PPE and Esx Proteins
Are the Major Determinant of Immunodominance
To dissect whether the main determinant of immunodominance
was related to a given antigen being contained within an antigenic
island or belonging to PE/PPE and Esx proteins families, we
calculated the percentage of the total response for different groups
of proteins as well as the percentage of the MTB genome
associated with these protein groups (Table 2). To compare
different protein groups we calculated the ratio between % of
response and % genome, as a percent enrichment.
The PE/PPE proteins were responsible for 19% of the total
response, and when divided into PE/PPE proteins within an island
compared to non-island, the island PE/PPE were more predictive
of immunogenicity than the non-island ones (Table 2). Also, in the
case of Esx proteins and T7SS, proteins within the antigenic
islands were more likely to be immunogenic than those outside the
islands. Proteins not in the antigenic islands, and not belonging to
PE/PPE and T7SS categories, were responsible for 14% of the
total response (Table 2). Thus, these data show that the antigenic
islands identified are highly predictive of immunogenicity, and that
to be contained within the antigenic islands is the most reliable
predictor of the immunodominance of PE/PPE and Esx proteins.
Similar Multifunctionality of T Cell Responses to Different
Categories of MTB Antigens
It has been proposed that some of the responses against secreted
MTB proteins act as decoys [13], thereby supporting bacterial
persistence. It has also been proposed that T cells differing in their
degree of multifunctionality might differ in terms of protective
potential, or have a role in pathology [31,32,33,34]. Definition of
dominant antigens allows testing the validity of these hypotheses.
To address these issues we detailed responses against PE/PPE, Esx
and other proteins expressed in the three major antigenic islands,
or elsewhere, by a variety of approaches, including multiparameter
intracellular cytokine staining (ICS) assays, tetramer staining and
T cell libraries.
The frequency of IFN-c, TNFa, and IL-2 expressing CD4 T
cells elicited by proteins from the PE/PPE and cell wall and cell
processes category, and from within an island versus non-island,
induced similar cytokine expression patterns (Figure 4A and C;
gating strategy in Figure S3). The vast majority of CD4+ T cells
were IFN-c+TNFa+IL-2+ or IFN-c+TNFa+, followed by TNFa+
single producing CD4+ T cells. To a lesser extent, TNFa+IL-2+,
single IFN-c+, and single IL-2+ cells were also detected (Figure 4A
and C). Triple cytokine producers were found in 27–40% of
cytokine-expressing CD4+ T cells, 30–43% expressed any 2
cytokines, and 23–44% produced a single cytokine (Figure 4B and
D). We did not observe any donor-, antigen- or epitope-specific
pattern of cytokine production (Figure 4E).
Memory Phenotypes and T Cell Subsets Associated with
Different Categories of MTB Antigens
CD4+ T cells were stained with selected HLA-epitope tetramer
reagents and tetramer+ cells were enriched [8,35]. Epitope-specific
T cell responses were detected in 16 donors at frequencies 0.25 to
24.3% (median of 3.8, interquartile range 1.5–15.3) for seven
different HLA/T cell epitope tetramer combinations (Figure 5A).
Only a small number of tetramer-positive cells were detected with
the epitope-specific tetramers in donors with a HLA mismatch
(Figure 5A), which confirmed that tetramer specificity was derived
from the epitope and HLA molecule combination. Epitope
Figure 1. Breadth and dominance at the epitope and antigen level. (A) Epitopes ranked on the basis of magnitude of response. LTBI (black
line - % of total response, grey line – total SFC) and TB uninfected (grey dashed line – total SFC) donors. Black dashed lines indicate the top 80 and
175 epitopes. (B) Antigens ranked on the basis of the response frequency for LTBI donors. Black dashed line indicates antigens recognized by .10%
of LTBI donors. (C) Antigens ranked on the basis of magnitude of response and response frequency (black line - % of total response, grey line – total
SFC). Black dashed line indicates the top 82 antigens.
doi:10.1371/journal.ppat.1003130.g001
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tetramer combinations were selected based on the number of
donors responding, HLA restriction, and the availability of
corresponding reagents for tetramer production. Memory subset
phenotypes were determined using Abs to CD45RA and CCR7.
Similar to the multifunctionality phenotype, we did not observe
any differences in memory phenotype when comparing proteins
from within an island vs. non-island (Figure 5B and C). Rv0129c/
Rv1886/Rv3804, Rv3418c and Rv1195 epitope-specific tetra-
mer+ T cells predominantly consisted of CD45RA2CCR7+
central memory T cells in all donors analyzed, followed by
effector memory (CD45RA2CCR72). Percentages ranged be-
tween 70.1 and 91.3% (median 85.0, interquartile range (77.7–
86.8)) for central memory T cells and 8.6–26.8% (13.3 (10.2–19.0))
for effector memory T cells. Only a minor fraction appeared to be
naı¨ve (CCR7+CD45RA+) or effector T cells (CCR72CD45RA+).
For Rv0288/Rv3019c the percentages ranged between 49.5 to
84.5% (56.8 (52.0–74.7)) for central memory T cells, 9.8–37.1%
(25.9 (13.3–33.8)) for naı¨ve and 4.8–17.2% (10.0 (7.4–16.8)) for
effector memory T cells. Again, a minor fraction of the tetramer+
cells appeared to be effector T cells (Figure 5B and C).
The T Cell Response to MTB Is Restricted to a
CXCR3+CCR6+ Memory Subset
To measure frequency and distribution of MTB-specific T cells,
we used the T cell library method [26]. The majority of epitope-
specific tetramer+ cells were found to be CD45RA2. We therefore
stained CD45RA2CD252 CD4 T cells from donors latently
infected with TB (LTBI) with antibodies against chemokine
receptors preferentially expressed on functionally distinct memory
Table 1. Summary of characteristics of novel CD4 T cell antigens recognized by more than 10% of LTBI donors, ranked according
to response frequency.
Rv-number Resp. freq. Total SFC Protein category Location T7SS
Rv3024c 32% 1630 Information pathways Island 2 -
Rv0289 29% 2298 Cell wall and cell processes Island 1 Esx-3
Rv0290 29% 1552 Cell wall and cell processes Island 1 Esx-3
Rv3330 29% 1595 Cell wall and cell processes Non-island -
Rv1788 25% 347 PE/PPE Non-island Esx-5
Rv1791 25% 355 PE/PPE Non-island Esx-5
Rv3125c 21% 125 PE/PPE Non-island -
Rv0294 18% 1368 Intermediary metabolism and respiration Island 1 -
Rv2874 18% 798 Intermediary metabolism and respiration Non-island -
Rv3022c 18% 109 PE/PPE Island 2 -
Rv3135 18% 317 PE/PPE Non-island -
Rv3876 18% 1323 Cell wall and cell processes Island 3 Esx-1
Rv0124 14% 177 PE/PPE Non-island -
Rv0291 14% 1153 Intermediary metabolism and respiration Island 1 Esx-3
Rv0292 14% 708 Cell wall and cell processes Island 1 Esx-3
Rv0293c 14% 1073 Conserved hypotheticals Island 1 -
Rv0297 14% 154 PE/PPE Non-island -
Rv0299 14% 467 Conserved hypotheticals Non-island -
Rv3012c 14% 233 Information pathways Non-island -
Rv3025c 14% 423 Intermediary metabolism and respiration Island 2 -
Rv0278c 11% 45 PE/PPE Non-island -
Rv0279c 11% 45 PE/PPE Non-island -
Rv0298 11% 783 Conserved hypotheticals Non-island -
Rv0442c 11% 232 PE/PPE Non-island -
Rv0690c 11% 233 Conserved hypotheticals Non-island -
Rv0985c 11% 70 Cell wall and cell processes Non-island -
Rv0987 11% 133 Cell wall and cell processes Non-island -
Rv1172c 11% 237 PE/PPE Non-island -
Rv1243c 11% 114 PE/PPE Non-island -
Rv1317c 11% 97 Information pathways Non-island -
Rv1366 11% 308 Conserved hypotheticals Non-island -
Rv1441c 11% 86 PE/PPE Non-island -
Rv2490c 11% 64 PE/PPE Non-island -
Rv2853 11% 85 PE/PPE Non-island -
doi:10.1371/journal.ppat.1003130.t001
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T cell subsets [36]. Five Th cell subsets were sorted: 1)
CXCR3+CCR62; 2) CXCR3+CCR6+, both enriched in Th1
cells; 3) CCR4+CCR62 (Th2); 4) CCR4+CCR6+ (Th17); and 5)
CCR6+CCR10+ (Th22) [5]. MTB-specific T cells were almost
exclusively found in the CXCR3+CCR6+ subset, while Flu-specific
T cells were in the CXCR3+CCR62 and CXCR3+CCR6+
subsets, and Candida albicans-specific T cells were most prominent
in the CCR4+CCR6+ subset, enriched in Th17 cells, but positive
cultures were also detected in libraries from subsets enriched in
Th1, Th2 and Th22 cells (Figure 6A and B). The narrow
distribution of antigen-responding T cells in the CXCR3+CCR6+
subset was peculiar to MTB since Streptococcus pyogenes- or
Staphylococcus aureus-specific T cells were found in both
CXCR3+CCR6+ and CCR4+CCR6+ subsets (not shown).
Based on these results, we sorted three memory CD4 Th cell
subsets (Figure 7A and B): 1) CCR6+CXCR32, accounting for
24.1% (21.8–27.0) (median (interquartile range), n = 4) of the
memory CD4+ T cell pool; 2) CCR6+CXCR3+ (32.0% (28.0–
32.4)) and 3) CCR62 (37.0% (34.4–42.0)). For each donor a T cell
library of 288 cultures was established. MTB-responding T cells
were highly enriched in cultures derived from the
CCR6+CXCR3+ T cell subset, and present at much lower
frequency in the CCR6+CXCR32 and the CCR62 subsets
(Figure 7C). This pattern of distribution was remarkable consis-
tent: in all 4 donors analyzed more than 80% of the MTB-reactive
memory CD4 T cell response resided in the CXCR3+CCR6+
subset (Figure 7D).
Next, we set up T cell libraries from 4 representative donors and
the CXCR3+CCR6+ subset were directly stimulated, after
expansion, with 59 representative peptide pools. The results of
this analysis are shown in figure 8. Using this approach we were
able to demonstrate that the results obtained with the MTB lysate
also extended to responses specific for the various epitopes, and to
confirm with a complementary approach the results of the ex vivo
IFN-c ELISPOT analysis utilizing the library of predicted HLA
class II binding epitopes.
Discussion
Individual MTB proteins have been studied to identify novel vaccine
candidates, with several studies focused on culture filtrate proteins
[6,7]. Other studies utilized bioinformatic approaches to select a subset
of genes as antigen candidates [37,38]. However, the lack of a true
genome-wide characterization has hindered a complete understanding
of the mechanisms and specificity of the immune response to MTB.
This study provides the first in-depth truly genome-wide
description of human T cell responses to MTB. We characterized
and isolated T cells directly ex vivo, thus avoiding biases
Figure 2. Protein categories of identified antigens. The identified antigens (black bars) were divided into protein categories (TubercuList) and
compared to the MTB genome (grey bars). Chi-square test, ***, p,0.001, ****, p,0.0001.
doi:10.1371/journal.ppat.1003130.g002
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introduced as a result of in vitro restimulation and expansion of T
cells before analysis. This approach should be generally applicable
to the study of immunity to other complex pathogens. The HLA
alleles were chosen to allow coverage of the most frequent DP, DQ
and DR specificities in the general population [39]. However, we
readily acknowledge that this selection has potential limitations
and may bias the results toward the epitopes recognized by these
alleles.
In terms of T cells recognizing MTB we found that the T cell
response to MTB antigens in LTBI donors is strongly biased
towards a subset of CXCR3+ Th1 cells that co-express CCR6 [4].
Interestingly, this narrow distribution was only seen for MTB and
not other pathogens such as S. pyogenes and C. albicans within the
same donor. The origin of CCR6+ Th1 cells and their
differentiation requirements remains to be defined; they may
represent a separate Th1 lineage, or they may differentiate from
plastic CCR62 Th1 cells or CCR6+ Th17 cells [40]. Future
studies will examine whether this highly focused response is key to
MTB containment by examining patients who remain healthy vs.
patients who progress to active disease.
Figure 3. Antigens cluster in antigenic islands in the MTB genome. (A) All antigens recognized on the H37Rv genome map, % donors
responding (black bars) and % of total response (red dotted line). (B) Antigenic islands identified by a 5-gene window spanning the entire MTB
genome (top panel); Binomial distribution and Bonferroni correction, *, p,0.01. Proteins within each antigenic island, % donors responding (black
bars) and % of total island response (grey bars) and the % of total (all antigens recognized) response per island (middle panel). Cartoons show relative
length of proteins, direction of transcription and protein category of each protein. Esx proteins are part of the cell wall and cell processes category.
doi:10.1371/journal.ppat.1003130.g003
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Striking levels of heterogeneity of responses were detected. This
expands previous observations using smaller subsets of antigens
[6,41], and a genome-wide screen of antibody responses [28]. The
observed heterogeneity might reflect differences in MTB strains,
bacillary load, and metabolic state, resulting in qualitative or
quantitative differences in antigen expression [42,43]. In any case,
since natural immunity to MTB is multiepitopic and multi-
antigenic, and more than 80 antigens are necessary to capture
80% of the T cell response, vaccination strategies including one or
a few antigens are unlikely to replicate natural immunity. Likewise,
monitoring the immune response to one or a few antigens in the
setting of clinical trials might yield a severely incomplete and
biased picture of immune reactivity.
Several antigens from the DosR regulon, as well as resuscita-
tion- and reactivation-associated antigens have been described as
preferentially recognized by individuals with latent infection using
long-term T cell cultures [44,45]. We observed reactivity to two of
these proteins, Rv2031c (2 donors) and Rv2627c (1 donor), and no
significant association with proteins from the DosR regulon or
latency-associated antigens, similar to previous observations [46].
Numerous tuberculosis vaccine candidates are currently in
clinical trials, these candidates are based on 11 MTB antigens, 7 of
which were prevalently recognized in this study; Rv3804c in
MVA85A [47] and Aeras-402 [48], Rv1886c in Aeras-402, H1
[49] and HyVac4 [50], Rv0288 in Aeras-402 and HyVac4,
Rv3875 in H1 and H56 [51], Rv1196 in Mtb72f/AS02A [52],
Rv2608 and Rv3619 in ID93 [53]. Of the remaining 4 antigens
Rv3620c in ID93 was also recognized whereas Rv2660c in H56,
Rv0125 in Mtb72f/AS02A and Rv1813c in ID93 were not.
We identified three antigenic islands within the MTB genome
map as main determinants of immunodominance. Remarkably,
the majority of the novel antigens identified are associated
(contained within or in close proximity to) these islands, which
all contain Esx protein pairs and PE/PPE proteins, and are part of
a putative secretory system. Our analysis demonstrated that these
factors synergistically contribute to determining immunodomi-
nance and confirms the importance of PE/PPE and Esx proteins,
but suggests that their immunodominance is perhaps mostly
determined by their location within these antigenic islands.
Two main hypotheses can be put forth to explain the
mechanism by which these features determine immunodomi-
nance. First, secreted proteins may act as decoys to divert the
immune response from recognizing nonsecreted MTB proteins
[13], thus favoring bacterial persistence. The second hypothesis
envisions that antigenic islands are dominant because they are
intrinsically immunogenic, and because they perform key biolog-
ical functions necessary to maintain MTB persistence.
The decoy hypothesis has two predicated features; either
secreted proteins result in diversion of the immune system from
the bacteria itself, or the decoy effect is achieved by inducing an
immune response to decoy antigens that are functionally distinct
from non-decoy antigens. In the first case, we note that both
secreted proteins and proteins involved in the secretion apparatus
are equally recognized. Indeed, immune reactivity towards
proteins involved in the secretion system apparatus has previously
been described for T3SS and inflammasome activation by flagellin
and the T3SS rod proteins [54,55]. Furthermore, we were unable
to detect a functionally distinct immune response in terms of
multifunctionality, memory phenotype and T cell subsets, and
independent of island vs. non-island localization and secretion
status of the antigen recognized. Taken together, these observa-
tions argue against the decoy hypothesis. T cells that secrete
multiple cytokines are a potential correlate of protection, but have
also been implicated in pathology [31,32,33,34]. Whatever their
role might be, the majority of epitope-specific CD4+ T cell
responses were multifunctional, with no differences between
antigens from islands vs. non-islands, and between the PE/PPE
vs. cell wall and cell processes categories. In terms of T cell
phenotypes and T cell subsets a similar picture emerged, with
epitope specific CD4+ T cells being predominantly
CD45RA2CCR7+ central memory cells, in agreement with
previous studies [26]. For some epitope specific CD4+ T cells a
large fraction were CD45RA+CCR7+, a phenotype traditionally
regarded as naı¨ve. Such T cells have previously been reported
[56,57], and might reflect early differentiation into antigen-specific
Table 2. Immunodominance of islands, PE/PPE, Esx and T7SS proteins.
% donors responding % of total response No. proteins % of total MTB genome
% Enrichment (% response/%
genome)
Islands total 89 42.2 22 0.55 76.7
Island 1 79 20.4 9 0.23 88.7
Island 2 86 15.0 9 0.23 65.2
Island 3 50 6.8 4 0.10 68.0
PE/PPE total 71 19.2 38 0.95 20.2
PE/PPE non-island 71 14.0 32 0.80 17.5
PE/PPE island 46 5.2 6 0.15 34.6
Esx proteinsa total 75 19.6 11 0.28 70.0
Esx proteins non-island 11 1.2 5 0.13 9.2
Esx proteins island 75 18.5 6 0.15 123.3
T7SSb total 79 34.7 16 0.40 86.8
T7SS non-island 39 7.0 6 0.15 46.6
T7SS island 75 27.7 10 0.25 110.8
Other 82 14.2 23 0.58 24.5
a) Esx proteins include EsxA-W.
b) T7SS includes the Esx proteins.
doi:10.1371/journal.ppat.1003130.t002
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Figure 4. Cell wall/cell processes and PE/PPE specific CD4 T cells have a multifunctional phenotype. Epitope-specific IFN-c, TNFa and IL-
2 production by PBMCs from LTBI donors measured after 6 h peptide stimulation. (A, C) % of responding CD4+ expressing each of the seven possible
combinations of IFN-c, TNFa and IL-2 (A) cell wall and cell processes proteins, (C) PE/PPE proteins. Island proteins (black dots) and non-island (grey
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cells. Additional studies would be required to investigate this
further.
The available data favors the second hypothesis, that the three
antigenic islands are dominant because they perform key
biological functions and are necessary to maintain MTB persis-
tence. The most prevalently recognized island is Esx-3, which is
controlled by the iron-dependent regulator IdeR and the zinc
uptake regulator Zur [58,59], suggesting its involvement in
fundamental biological processes such as metal iron homeostasis.
In addition, Esx-3 is essential for in vitro growth, and is conserved
in a wide range of mycobacterial species [20,60]. Furthermore, the
Esx-3 system contributes to immune protection against MTB
challenge in mice of the IKEPLUS strain [61] in a HLA class II
dependent fashion.
Genes from island 2 are, like island 1 (Esx-3), regulated by Zur
[58], providing a possible functional link between them. While
island 2 is not part of an Esx secretion system per se, it is believed to
originate from a duplication of the Esx-3 system [19]. Esx-1 and
Esx-3 also appear to be linked, since Rv3873 interacts with
Rv0288 [62].
Secretion systems similar to the T7SS associated with two of the
three antigenic islands are also found in other bacteria, such as
Listeria monocytogenes, S. aureus, and Bacillus anthrax [63]. Secretion of
the substrates from T7SS are not dependent on interaction with
host cells, unlike other bacterial secretion systems such as T3SS
and T4SS, which are switched on upon host-cell contact. This
suggests that T7SS, while essential for pathogenicity, may fulfill
more general physiological roles than strictly host-cell oriented
functions.
This study was completed in a non-TB-endemic population.
Ongoing studies include a larger study population from different
ethnicities and geographic locations, as well as patients with
different disease states and BCG vaccination status. This will
provide answers for different HLA phenotypes, as well as whether
patients from an endemic area or with different disease states show
a different recognition pattern.
In conclusion, this study describes the immunological footprint
of MTB CD4 T cell recognition to an unprecedented level of
detail. The high throughput cellular screens utilized here to
analyze the human immune response to MTB provides informa-
tion on the specificity, frequency and class of memory T cells, as
well as on the individual variability in magnitude and quality of the
response. As a result, 34 novel antigens and three broadly
immunodominant antigenic islands were defined. The study of the
class of proteins recognized, together with the phenotype of
responding T cells, disproves the notion that responses against
secreted antigens are a decoy utilized to favor bacterial persistence,
and rather suggest that these proteins, together with those that are
part of their general secretion apparatus, are targeted by fully
functional T cell responses. More broadly, this study provides
proof of principle of how such high throughput techniques can be
applied to other complex pathogen systems. In terms of potential
practical applications, the novel T cell antigens identified could be
of potential use for diagnostic or vaccine purposes. Indeed, the
heterogeneity of responses demonstrated herein suggests that a too
narrow focus for vaccine evaluations will not replicate natural
immunity. Finally, the antigens and epitopes identified can also be
used as tools for identifying biomarkers to provide correlates of risk
for, or protection against, tuberculosis disease.
Materials and Methods
Ethics Statement
Research conducted for this study was performed in accordance
with approvals from the Institutional Review Board at the La Jolla
Institute for Allergy and Immunology. All participants provided
written informed consent prior to participation in the study.
Study Subjects
Leukapheresis samples from 28 adults with LTBI and 28 control
donors were obtained from the University of California, San
Diego Antiviral Research Center clinic (age range 20–65 years).
Subjects had a history of a positive tuberculin skin test (TST).
LTBI was confirmed by a positive QuantiFERON-TB Gold In-
Tube (Cellestis), as well as a physical exam and/or chest X-ray
that was not consistent with active tuberculosis. None of the study
subjects endorsed vaccination with BCG, or had laboratory
evidence of HIV or Hepatitis B. The control donors had a
negative TST, as well as a negative QuantiFERON-TB. Approval
for all procedures was obtained from the Institutional Review
Board (FWA#00000032) and informed consent was obtained
from all donors.
Bioinformatic Analyses
Proteins from the 21 MTB genome projects available from the
NCBI Protein database were downloaded into an in-house
MySQL database. Of these, 5 were complete (CDC1551, F11,
H37Ra, H37Rv, KZN 1435) and 16 were draft assemblies (Table
S1). The protein sequences were parsed into all possible 15mer
peptides (n = 1,568,148), for each of which binding to 22 different
HLA DR, DP and DQ class II alleles most commonly expressed in
the general population (Table S2) was predicted using the IEDB
HLA class II ‘consensus’ prediction method [64]. The sequences
of the H37Rv strain were used as a reference sequence. For each
H37Rv protein, alignments were made of all orthologs identified
in other genomes, as determined by a BLAST search. Because of
the overall high sequence conservation among the proteins from
all the 21 genomes, 1,220,829 (91.4%) of 15mers were completely
conserved among all of the strains. For each protein, the best-
predicted binders, as ranked by consensus percentile, were selected
for synthesis. In order to ensure coverage of each of the proteins,
the number of peptides selected per protein was no less than 2 and
no more than 10, depending upon protein length (18,950
peptides). Any variants among the orthologs at the selected
positions were also selected (1,660), for a total of 20,610 peptides.
Peptides
Sets of 15-mer peptides synthesized by Mimotopes (Victoria,
Australia) and/or A and A (San Diego) as crude material on a
small (1 mg) scale were combined into pools of 20 peptides.
Peptides utilized for tetramers were synthesized as purified
material (.95% by reversed phase HPLC). The IEDB submission
number for the peptides is 1000505.
dots). Each dot represents one donor/epitope combination median 6 interquartile range is indicated. (B, D) The fraction of the total cytokine
response against (B) cell wall and cell processes, (D) PE/PPE proteins, expressing all 3, 2 or 1 cytokine. (E) Heat-map of each of the seven possible
combinations of IFN-c, TNFa and IL-2 for each individual donor and epitope tested grouped by protein category and island localization. Each column
represents one donor. Colors indicate frequency of epitope-specific CD4 T cells, grey is considered negative for indicated cytokine production.
Multiple proteins indicate that the peptide sequence is homologous in these proteins.
doi:10.1371/journal.ppat.1003130.g004
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Figure 5. Memory phenotype of MTB-specific CD4 T cells using HLA class II tetramers. (A) HLA class II tetramer stained CD4-purified cells
from LTBI donors. Tetramer+ cells were isolated following magnetic bead enrichment. Plots are gated on CD4+ T cells, and the numbers indicate the
percentage of tetramer+ cells isolated from each of 4 representative donors CD4+ population. DPB1*04:01 AGCQTYKWETFLTSE n = 4 donors,
DRB1*15:01 MHVSFVMAYPEMLAA n = 3, DRB1*15:01 MSQIMYNYPAMMAHA n = 5 and DRB1*01:01 GEEYLILSARDVLAV n = 2. (B) Memory phenotype of
tetramer+ cells for one representative donor per tetramer. Plots are gated on total CD4+ T cells (black background) or epitope-specific CD4+ T cells
(red dots). The numbers represent the percentages of tetramer+CD4+ T cells in the gate. (C) Scatter plot of the proportion of CCR72CD45RA2 (effector
memory), CCR7+CD45RA2 (central memory), CCR7+CD45RA+ (naı¨ve), and CCR72CD45RA+ (effector) CD4+ T cells for each tetramer. Each dot
represents one donor/tetramer combination, median 6 interquartile range is indicated.
doi:10.1371/journal.ppat.1003130.g005
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PBMC Isolation
PBMCs were obtained by density gradient centrifugation
(Ficoll-Hypaque, Amersham Biosciences) from 100 ml of leuka-
pheresis sample, according to manufacturer’s instructions. Cell
were suspended in fetal bovine serum (Gemini Bio-products)
containing 10% dimethyl sulfoxide, and cryo-preserved in liquid
nitrogen.
T Cell Library
CD4 T cells were isolated from PBMCs by positive selection
with microbeads (Miltenyi Biotec). Memory CD4+ T cell subsets
were sorted with a FACSAria (BD Biosciences) to over 98% purity
excluding CD45RA+, CD25+, CD8+, CD19+, and CD56+ cells.
Antibodies used for positive selection were: anti-CCR6-PE or
biotinylated (11A9; BD Biosciences) followed by streptavidin-
allophycocyanin (APC) (Invitrogen) or streptavidin-APC-cyanine7
(APC-Cy7) (BD Biosciences); anti-CCR10-PE (314305, R&D
Systems), anti-CCR4-PE-Cy7 (1G1; BD Pharmingen) and anti-
CXCR3-APC (1C6; BD Pharmigen). Cells were cultured in RPMI
1640 medium supplemented with 2 mM glutamine, 1% (vol/vol)
nonessential amino acids, 1% (vol/vol) sodium pyruvate, penicillin
(50 U/ml), streptomycin (50 mg/ml) (all from Invitrogen) and 5%
heat-inactivated human serum (Swiss Red Cross). T cells (1,000
cells/well) were stimulated polyclonally with 1 mg/ml PHA
(Remel) in the presence of irradiated (45 Gy) allogeneic feeder
cells (1.06105 per well) and IL-2 (500 IU/ml) in a 96-well plate
format and T cell lines were expanded as previously described
[26]. Library screening was performed at day 14–21 by culturing
extensively washed T cells (,2.56105/well) with autologous
monocytes (2.56104), either unpulsed or pulsed for 3 h with
MTB whole cell lysate (5 mg/ml, BEI Resources) or control
antigens. In some experiments, T cells were cultured with peptide
pools (2 mg/ml). Proliferation was measured on day 2–3 after 16 h
incubation with 1 mCi/ml [methyl-3H]-thymidine (Perkin Elmer).
Figure 6. T cell responses to MTB are restricted to a CXCR3+CCR6+ memory subset. Memory CD4 T cells were sorted into five subsets, 1)
CXCR3+CCR62, 2) CXCR3+CCR6+, 3) CCR4+CCR62, 4) CCR4+CCR6+, and 5) CCR6+CCR10+. The sorted T cells were polyclonally expanded and analyzed
for the presence of MTB-, Influenza A- and C.albicans-specific T cells by stimulation with whole cell lysates in the presence of autologous monocytes
and assessed for 3H-thymidine incorporation. Results are from one representative donor of more than 10 tested. (A) Shown is proliferation of
individual cultures as cpm. Dotted lines represent the cut-off value. (B) Shown is the estimated frequency of antigen-specific T cells per 106 cells in
each Th cell subset for the three organisms used for stimulation.
doi:10.1371/journal.ppat.1003130.g006
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Precursor frequencies were calculated based on numbers of
negative wells according to the Poisson distribution and expressed
per million cells.
Ex Vivo IFN-c ELISPOT Assay
PBMCs incubated at a density of 26105 cells/well were
stimulated with peptide pools (5 mg/ml) or individual peptides
(10 mg/ml), PHA (10 mg/ml) or medium containing 0.25%
DMSO (corresponding to percent DMSO in the pools/peptides,
as a control) in 96-well plates (Immobilon-P; Millipore) coated
with 10 mg/ml anti-IFN-c (AN18; Mabtech). Each peptide or pool
was tested in triplicate. After 20 h incubation at 37uC, wells were
washed with PBS/0.05% Tween 20 and incubated with 2 mg/ml
biotinylated anti-IFN-c (R4-6A2; Mabtech) for 2 h. The spots
were developed using Vectastain ABC peroxidase (Vector
Laboratories) and 3-amino-9-ethylcarbazole (Sigma-Aldrich) and
counted by computer-assisted image analysis (KS-ELISPOT
reader, Zeiss). Responses were considered positive if the net
spot-forming cells (SFC) per 106 were $20, the stimulation index
$2, and p,0.05 (Student’s t-test, mean of triplicate values of the
response against relevant pools or peptides vs. the DMSO control).
For experiments utilizing depletion of CD4+ or CD8+ T cells,
these cells were isolated by positive selection (Miltenyi Biotec) and
effluent cells (depleted cells) were used for experiments.
The response frequency was calculated by dividing the no. of
donors responding with the no. of donors tested. The magnitude of
response (total SFC) was calculated by summation of SFC from
responding donors.
Intracellular Cytokine Staining
PBMCs were cultured in the presence of 5 mg/ml MTB peptide
and 4 ml/ml Golgiplug (BD Biosciences) in complete RPMI
medium at 37uC in 5% CO2. Unstimulated PBMCs were used to
assess nonspecific/background cytokine production. After 6 h,
cells were harvested and stained for cell surface antigens CD4
(anti-CD4-PerCPCy5.5, OKT-4) and CD3 (anti-CD3-EFluor450,
UCHT1). After washing, cells were fixed and permeabilized, using
a Cytofix/Cytoperm kit (BD Biosciences) and then stained for
IFN-c (anti-IFN-c-APC, 4S.B3), TNFa (anti-TNFa-FITC,
MAb11) and IL-2 (anti-IL-2-PE, MQ1-17H12). All antibodies
were from eBioscience. Samples were acquired on a BD LSR II
flow cytometer. The frequency of CD4+ T cells responding to each
MTB peptide was quantified by determining the total number of
gated CD4+ and cytokine+ cells and background values subtracted
(as determined from the medium alone control) using FlowJo
software (Tree Star). A cut-off of 2 times the background was used.
Combinations of cytokine producing cells were determined using
Boolean gating in FlowJo software.
Tetramer Staining
HLA class II tetramers conjugated using PE labeled streptavidin
were provided by the Tetramer Core Laboratory at Benaroya
Research Institute. CD4 T cells were purified using the Miltenyi T
cell isolation kit II according to manufacturer’s instructions.
Figure 7. The T cell response to MTB is restricted to a
CXCR3+CCR6+ memory subset. (A, B) Three CD45RA2CD252CD4+
memory T cell subsets from four LTBI donors were sorted; 1)
CCR6+CXCR32; 2) CCR6+CXCR3+; and 3) CCR62. (A) Representative dot
plot from one donor; (B) Median percentages of the T cell subsets on
total CD4+ memory T cells. Error bars indicate interquartile range (n = 4).
(C) T cell libraries were set up from the sorted subsets by polyclonal
stimulation and expansion for 3–4 weeks. Libraries were analyzed by
stimulation with autologous monocytes with or without MTB whole cell
lysate and proliferative response was measured by 3H-thymidine
incorporation. Shown is the estimated frequency of MTB-specific T
cells per 106 CD4 memory T cells for LTBI donors. (D) Distribution of
MTB-specific T cells in the three memory T cell subsets. Data represent
median 6 interquartile range from four donors. Mann Whitney test, *,
p,0.05.
doi:10.1371/journal.ppat.1003130.g007
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Purified cells (,106106) were incubated in 0.5 ml PBS containing
0.5% BSA and 2 mM EDTA pH 8.0 (MACS buffer) with a 1:50
dilution of class II tetramer for 2 h at room temperature. Cells
were then stained for cell surface antigens using anti-CD4-FITC
(OKT-4), anti-CD3-Alexa Fluor 700 (OKT3), anti-CCR7-PerC-
PEFluor710 (3D12), anti-CD45RA-EFluor450 (HI100) (all from
EBioscience) and Live/Dead Yellow (Life Technologies) to
exclude dead cells. Tetramer-specific T cell populations were
enriched by incubating cells with 50 ml of anti-PE microbeads
(Miltenyi Biotech) for 20 min at 4uC. After washing, cells were
resuspended in 5 ml MACS buffer and passed through a
magnetized LS column (Miltenyi Biotec). The column was washed
three times with 3 ml of MACS buffer, and after removal from the
magnetic field, cells were collected with 5 ml of MACS buffer.
Samples were acquired on an BD LSR II flow cytometer and
analyzed using FlowJo software.
Antigen and IEDB Analysis
The identified epitopes were compared for sequence homology
and the weakest epitopes sharing .90% homology were
eliminated. The epitopes were mapped to the H37Rv genome
allowing 1 substitution per peptide, to identify antigens. IEDB
queries utilized criteria matching the experimental study (organ-
ism; MTB, host organism; human, latent disease, ex vivo, HLA
class II). Epitopes were then mapped as above. To capture the
most frequently recognized antigens the response frequency score
(no. donors responded – Square root of no. donors responded/no.
donors tested), was utilized [65].
Supporting Information
Figure S1 Experimental design. Summary of the steps
involved in the antigen identification pipeline, showing number
of genomes, 15-mer peptides and selected peptides.
(EPS)
Figure S2 Novelty of the antigens identified as a source
of CD4 epitopes in humans. (A) Comparison with IEDB and
literature, antigens were divided into four categories; novel, targets
of CD4 T cells, CD8 T cells or undefined T cell type. 41% of
defined antigens are novel. (B) Overlap of antigens described in
this study with antigens described as sources of HLA class I
restricted epitopes in the IEDB. (C) Overlap of antigens described
in this study with antigens described as serologically reactive by
Kunnath-Velayudhan et al. p-values calculated using a Chi-square
test.
(EPS)
Figure S3 Gating strategy for multifunctionality analy-
sis. Cells were first gated based on forward vs. side-scatter, then
CD3 vs. CD4 and finally for each cytokine (IFN-c, TNFa, IL-2).
Gates for each cytokine were based on the negative control and
they were used for subsequent Boolean gating.
(EPS)
Table S1 Summary of MTB genomes used for peptide
predictions.
(DOC)
Table S2 Haplotype and phenotype frequencies of HLA
class II alleles used for predictions.
(DOC)
Table S3 Summary of epitope characteristics.
(XLS)
Table S4 Summary of characteristics of antigens rec-
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